Señales en vivo de ARTL | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 11:48):

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system...

Stats
Volumen de hoy	5 102.00
Volumen promedio	14 977.00
Capitalización de mercado	4.38M
EPS	$0 ( 2024-03-29 )
Próxima fecha de ganancias	( $-1.050 ) 2024-06-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.430
ATR14	$0.0210 (1.60%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	Favorito Tamara A	Buy	2 000	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Buy	1 083	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Buy	667	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Sell	1 083	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Sell	2 000	Stock Option (right to buy)

INSIDER POWER
15.97
Last 100 transactions
Buy: 2 033 762 \| Sell: 346 866

Artelo Biosciences Inc Correlación

10 Correlaciones Más Positivas
CENT	0.916
RLAY	0.912
KNTE	0.907
GOODO	0.905
CENTA	0.897
SLDP	0.895
VERB	0.889
CSTR	0.884
CDW	0.881
NTRS	0.879

10 Correlaciones Más Negativas
NOVV	-0.898
ASLN	-0.887
SOUN	-0.86
QRTEP	-0.857
LTRY	-0.853
RPHM	-0.851
XOG	-0.85
OMER	-0.85
DHC	-0.846
ZGNX	-0.845

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Artelo Biosciences Inc Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-3.49

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-3.49

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.400

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.260

Financial Reports:

No articles found.

Artelo Biosciences Inc

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.